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ABSTRACT 
Angiotensin II (AngII) stimulates adrenocortical cells to produce aldosterone, a master regulator of 
blood pressure. Despite extensive characterization of the transcriptional and enzymatic control of 
adrenocortical steroidogenesis, there are still major gaps in the precise regulation of AII-induced gene 
expression kinetics. Specifically, we do not know the regulatory contribution of RNA-binding proteins 
(RBPs) and RNA decay, which can control the timing of stimulus-induced gene expression. To 
investigate this question, we performed a high-resolution RNA-seq time course of the AngII stimulation 
response and 4-thiouridine pulse labeling in a steroidogenic human cell line (H295R). We identified 
twelve temporally distinct gene expression responses that contained mRNA encoding proteins known 
to be important for various steps of aldosterone production, such as cAMP signaling components and 
steroidogenic enzymes. AngII response kinetics for many of these mRNAs revealed a coordinated 
increase in both synthesis and decay. These findings were validated in primary human adrenocortical 
cells stimulated ex vivo with AngII. Using a candidate screen, we identified a subset of RNA-binding 
protein and RNA decay factors that activate or repress AngII-stimulated aldosterone production. Among 
the repressors of aldosterone were BTG2, which promotes deadenylation and global RNA decay. BTG2 
was induced in response to AngII stimulation and promoted the repression of mRNAs encoding pro-
steroidogenic factors indicating the existence of an incoherent feedforward loop controlling aldosterone 
homeostasis. These data support a model in which coordinated increases in transcription and decay 
facilitates the major transcriptomic changes required to implement a pro-steroidogenic expression 
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INTRODUCTION 
Angiotensin II (AngII) is a potent octapeptide hormone that binds to angiotensin II receptor type 1 
(AGTR1) in adrenal zona glomerulosa cells to stimulate the production of the mineralocorticoid 
aldosterone from cholesterol. The primary function of aldosterone is to regulate blood pressure and 
volume through the control of renal salt excretion (Gross and Gysel 1954). Additional functions of 
aldosterone discovered more recently include directly mediating cardiac and vascular remodeling 
(Monticone et al. 2018; Feldman 2014). Aldosterone is a small, non-polar, and hydrophobic steroid 
hormone that passes through the cell membrane upon production. Given the lack of intracellular 
aldosterone, it must be produced de novo in response to steroidogenic stimuli. Thus, it is critical to 
tightly control the timing and amount of de novo aldosterone production. Pathological aldosterone 
excess, such as in primary aldosteronism, leads to hypertension and increased cardiovascular risk in 
humans (Monticone et al. 2018; Nanba et al. 2019; Brown et al. 2020). Although the stimulatory effect 
of AngII upon aldosterone secretion has been extensively studied, the temporal regulation of the AngII 
response, which is critical for maintaining aldosterone homeostasis, remains poorly understood.  
 
The temporal coordination of AngII-stimulated aldosterone biosynthesis is described in two stages: an 
“early regulatory step” (minutes) and a “late regulatory step” (hours) (Nogueira et al. 2009; Hattangady 
et al. 2012). The early regulatory step is characterized by rapid signaling pathways promoting 
cholesterol mobilization. A key part of the early step is inducing the expression of Steroidogenic Acute 
Regulatory Protein (STAR) that transports cholesterol from the outer to inner mitochondrial membrane 
allowing for conversion by CYP11A1 into the pregnenolone, which is a precursor for the production of 
all steroid hormones including aldosterone. The late regulatory step is characterized by inducing the 
expression of steroid biosynthesis enzymes such as aldosterone synthase (CYP11B2). Although the 
temporal order of the AngII gene expression response underlies both regulatory steps, there has not 
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been an examination of steroidogenic transcriptome dynamics with sufficient temporal resolution to 
systematically identify distinct response kinetics. 
 
There are two prototypical examples of coordinated temporal expression responses that feature 
different regulatory strategies. One example utilizes a cascade of transcription factor activity to 
generate waves of temporal expression patterns. Transcriptional cascades have been observed in the 
yeast cell cycle and innate immune responses (Luscombe et al. 2004; Smale 2012). The other example 
relies on intrinsic differences in the stability between induced transcripts to generate sequential 
response patterns. Specifically, the time to peak response is inversely correlated with the stability of 
the transcript, and thus unstable RNAs will exhibit more rapid induction and return to baseline than 
stable RNAs (Palumbo et al. 2015). This post-transcriptionally regulated model of temporal coordination 
of response kinetics has been observed largely in immune and inflammation responses (Hao and 
Baltimore 2009; Elkon et al. 2010; Rabani et al. 2011). Interestingly, increasing the decay rate of 
transcriptionally induced RNAs results in a kinetic response with a quicker time to peak expression and 
return to baseline. This strategy of increasing synthesis and decay has been observed in the yeast 
oxidative stress response and immune activation of mouse dendritic cells (Shalem et al. 2008; Rabani 
et al. 2014). A lack of response resolution in both of those biological systems would lead to deleterious 
effects for the cell and organism, much like the uncontrolled resolution of aldosterone production.  
 
RNA-binding proteins (RBPs) are a class of trans-acting regulatory factors that control all aspects of 
RNA metabolism (Gerstberger et al. 2014). Many RBPs have been shown to control the stability of 
mRNAs through interactions with cis-regulatory elements in the 3’ UTR of their target RNAs (Keene 
2007). RBPs binding to AU-rich elements are one of the most well-characterized examples for the 
regulation of RNA stability and have been associated with controlling the temporal order and shape of 
immune response kinetics (Elkon et al. 2010; Hao and Baltimore 2009; Rabani et al. 2014). General 
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regulators of RNA stability, such as factors that modify deadenylation, can also control the temporal 
response kinetics of induced RNAs and may do so in cardiac hypertrophy (Mauxion et al. 2008; Stupfler 
et al. 2016; Masumura et al. 2016). In spite of the importnace of RBPs in the regulation of decay, 
expression kinetics, and many other post-transcriptional processes, their role in AngII-mediated 
aldosterone production is poorly characterized. 
 
To understand the molecular basis and role of RNA regulation on the kinetics of the AngII-aldosterone 
gene regulatory program, we measured transcriptome dynamics at high-resolution applying RNA-seq 
on a steroidogenic human cell line (H295R) stimulated with AngII. While transcriptional control was 
clearly prominent, RNA decay rates determined the time to maximal change in expression. 
Furthermore, we observed AngII-dependent increases in RNA decay for many transcriptionally induced 
RNAs, including those encoding key pro-steroidogenic proteins. These findings were validated in 
primary human adrenocortical cells stimulated ex vivo. We identified RBPs and RNA decay factors that 
either activate or repress aldosterone production. Finally, we found that AngII-induced RNA decay 
factor BTG2 represses aldosterone production and promotes the clearance of steroidogenic RNAs. 
Together, these data support a model in which coordinated increases in transcription and RNA decay 
facilitates the major transcriptomic remodeling required to implement a pro-steroidogenic gene 
expression program that is temporally restricted to prevent aldosterone overproduction. 
 
RESULTS 
Identification of genes with temporally distinct AngII-response kinetics in H295R cells 
To delineate the temporal coordination of the AngII-induced gene expression response, we performed 
a high-resolution (twelve time points in duplicate) AngII stimulation RNA-seq time course in H295R 
cells (Figure 1A). Rather than polyA-enrichment, we performed rRNA depletion to enable measurement 
of both precursor and mature RNAs. The data were high quality as samples clustered first by replicates 
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(r ~ 0.99) and then time post-stimulation (Supplemental Figure 1A, 1B). First, we focused on changes 
in mature RNA (sum of all mature transcripts per gene, Supplemental Table 1). PCA analysis clearly 
indicated differences in gene expression as early as 15 minutes with the largest remodeling of the 
transcriptome occurring ~6-8 hrs post-stimulation (Figure 1B). Furthermore, the return towards the 
unstimulated state by 24 hrs suggests that this time course captures most of the AngII-induced changes 
in RNA levels in this system. Next, we determined the genes exhibiting statistically significant changes 
(FDR <= .001 and > 2-fold change) in mature RNA expression at any time point of AngII treatment 
versus unstimulated (n=2417). The changes in expression measured by RNA-seq were recapitulated 
(R > .95) by qRT-PCR for a subset of differentially expressed genes (Supplemental Figure 1C). 
Differentially expressed coding and long-noncoding RNAs both exhibited the largest change in 
expression between 3 and 8 hours (Figure 1C). Intriguingly, snRNAs appeared to be upregulated 
rapidly, peaking around 2 hrs before returning to baseline.  
To identify genes with similar temporal changes in expression, we performed K-means clustering on 
the mature expression level changes for the differentially expressed genes. This revealed 12 groups of 
genes with temporally distinct AngII-response kinetics (Figure 1D and Supplemental Figure 1D, 
Supplemental Table 2). The groups were labeled based on the direction (activated/repressed), 
magnitude (strong/weak), and timing of expression changes. For example, RNAs belonging to as1 
(activated strong 1), exhibited an average maximal activation of ~20-fold peaking around 1 to 2 hours, 
while RNAs in as4 (activated strong 4) exhibited an average maximal activation of ~4-fold peaking 
around 7 hrs. The as1 RNAs encoded proteins involved in the calcium and cyclic AMP signaling 
pathway that are activated during steroidogenesis (Figure 1E and supplemental Figure 1E), including 
NR4A1 and NR4A2, which are known transcriptional regulators of enzymes controlling aldosterone 
production (Romero et al. 2004; Bassett et al. 2004). Unexpectedly, we found a very strong enrichment 
for snRNAs, and particularly U1 snRNA, in aw1 (Supplemental Figure 1F). We observed a strong 
enrichment in as2 for mRNAs encoding proteins regulating the unfolded protein response. RNA-binding 
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proteins that control transcript-specific RNA decay were enriched in as2 and aw2. The aw3 and as3 
groups were enriched for mRNAs encoding steroid biosynthesis proteins. The induction of mRNAs 
encoding steroidogenic enzymes required for the conversion of cholesterol to aldosterone was 
consistent with previous studies validating the quality of the data (Figure 1F) (Romero et al. 2007; Wang 
et al. 2012). Altogether, our analysis demonstrated that AngII response kinetics exhibited temporal 
coordination of functionally related genes. 
  
RNA decay controls AngII response kinetics 
Simulations and previous studies in other stimulation-response paradigms have shown that the initial 
RNA decay rates in the unstimulated cells govern the time to peak expression response and thus the 
shape of the expression response (Rabani et al. 2011; Palumbo et al. 2015). Importantly, this 
phenomenon assumes constant decay rates throughout the response. As a starting point, we quantified 
the time to maximal expression change for each gene (see methods), which increased concordantly 
with peak time assigned to each group (Figure 2A, left). For example, genes in as1 (median 1.8 hrs) 
reached their peak expression 5.7x faster than those in as4 (median 10.9 hrs). Next to test if RNA 
decay rates governed maximal response kinetics in our system, we measured decay rates in 
unstimulated H295R cells using RNA metabolic labeling as we and others have done previously 
(Mukherjee et al. 2017; Milek et al. 2017). Cells were pulsed with 4-thiouridine (4sU) for 20 minutes 
and both total RNA and 4sU-labelled RNA were subject to rRNA depletion and RNA-sequencing, and 
synthesis, processing, and decay rates were calculated using INSPEcT for 11,668 genes in 
unstimulated H295R cells (Supplemental Figure 2A-C, Supplemental Table 3) (de Pretis et al. 2015). 
Our decay rates were consistent with established expectations for stable and unstable mRNAs 
confirming the validity of our measurements. As expected, transcripts encoding ribosomal proteins had 
low decay rates, while transcripts encoding immediate early genes had high decay rate (Supplemental 
Figure 2D). We found higher decay rates for RNAs in clusters that peaked earlier post AngII stimulation 
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(Figure 2B, right). For example, RNAs in as1 had a ~4.5x higher decay rate than RNAs in as4. Indeed, 
we observed an inverse relationship between the median decay rate and the median time to maximal 
induction for both strongly and weakly activated genes (Figure 2B). These results demonstrated that 
initial RNA decay rates in unstimulated cells play an important role in shaping AngII-response kinetics. 
  
Next, we ascertained putative regulatory mechanisms controlling RNA decay rates in steroidogenic 
cells. To identify possible RBPs or miRNAs regulating stability, we ranked mRNAs by decay rates and 
used cWords to identify 7-mers over-represented in the 3’ UTR sequence of unstable and stable RNAs 
(Rasmussen et al. 2013). Most of the significantly enriched motifs were associated with unstable RNAs 
versus stable RNAs. Therefore, we scored the top 500 7mers associated with instability for matches to 
RBP recognition motifs from external databases. These analyses revealed a striking enrichment for 
RBPs binding AU-rich elements (AREs), which are key determinants of RNA stability (Figure 2C). We 
also observed enrichment for RBPs regulating splicing and export, such as U2AF2 and RALY. These 
data identify putative RBPs and RNA regulatory elements that regulate RNA stability in unstimulated 
H295R cells. Assuming constant RNA decay rates throughout the AngII-response, higher decay rates 
in the unstimulated cells inversely correlate with time to peak expression in response to AngII 
stimulation (Figure 2B. Therefore, RBPs that control the RNA decay rates in unstimulated cells are 
important regulatory factors controlling AngII response kinetics and ultimately steroidogenesis.  
 
Increased RNA decay during steroidogenesis 
Having established the importance of initial RNA decay rates on AngII response kinetics, we next asked 
if there was evidence for changes in decay rate during the steroidogenic response. We compared 
changes in pre-mRNA versus mRNA levels to determine whether gene expression changes were better 
explained by transcriptional or post-transcriptional regulation. Specifically, we utilized reads aligning to 
introns versus exons to determine AngII-induced changes in levels of pre-mRNA and mRNA, 
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respectively (Gaidatzis et al. 2015; Alkallas et al. 2017; Mukherjee et al. 2017, 2019). We added the 
entire precursor RNA sequence and treated it as additional transcript isoform to specifically quantify 
precursor (Supplemental Table 4) and mature transcript levels using Salmon (Patro et al. 2017). As a 
first pass, we calculated the correlation between the changes in pre-mRNA and mRNA levels of genes 
encoding steroidogenic enzymes required for the conversion of cholesterol to aldosterone and found 
examples that are largely explained by changes in transcriptional regulation (high correlation), as well 
as examples indicative of changes in post-transcriptional regulation (low correlation) (Figure 3A). The 
same analysis was performed on all ~1500 differentially expressed genes with introns and sufficient 
intronic read support and revealed a broad distribution of correlation coefficients (Figure 3B). Each 
temporal group had many genes with low or negative correlation, indicating that changes in 
transcriptional regulation alone cannot explain the mature RNA changes. We also performed cross-
correlation to account for processing delays and observed similar results (Supplemental Figure 3A). 
These results suggested that many genes were experiencing stabilization or destabilization in response 
to AngII stimulation.  
 
To test the extent and direction of changes in post-transcriptional regulation, we performed exon-intron-
split analysis (EISA) using precursor and mature RNA estimates comparing all AngII-stimulated 
samples to the unstimulated baseline (see methods, Supplemental Table 5) (Gaidatzis et al. 2015). 
Filtering of the initial 2417 differentially expressed genes for the presence of introns and sufficient 
intronic read coverage resulted in 1194 genes that were analyzed. Among these genes a large majority 
(84% n=223) showed evidence of mRNA destabilization. Destabilized transcripts were significantly 
overrepresented in activated genes that had peak expression between 4-8 hours post AngII stimulation 
(as3, as4, aw2, aw3) (Figure 3C). Next, we examined AngII-induced genes with evidence for 
destabilization focusing on as4 and aw3, which contained many steroidogenic genes (Figure 1E). The 
amplitude of AngII-induced changes in precursor RNA were similar between genes with (blue lines) 
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and without evidence for destabilization (black lines), albeit the precursor RNAs for destabilized genes 
tend to peak earlier (Figure 3D, left). However, the changes in the mature RNA of destabilized genes 
(blue lines) were clearly suppressed relative to genes without evidence for post-transcriptional 
regulation (black lines) (Figure 3D, right). Included among the destabilized mRNAs were proteins 
encoding STAR, which is required for the proper and timely enzymatic conversion of cholesterol to 
steroid hormones, and MC2R (Lin et al. 1995), which is the ACTH receptor known to be induced by 
AngII stimulation (Lebrethon et al. 1994; Parmar et al. 2008) (Figure 3E). We identified potential RBPs 
responsible for the increased decay by searching for RBP binding motifs over-represented in the 3’ 
UTR of destabilized mRNAs belonging to aw3 and other clusters (Figure 3F) (Supplemental Figure 3B) 
enriched for destabilized mRNAs. Amongst these RBPs are known regulators of RNA decay ILF2, 
HNRNPL, CNOT4 of the CCR4-NOT deadenylation complex (Hui et al. 2003; Albert et al. 2000; Shim 
et al. 2002). None of the candidates exhibited differential expression in response to AngII, nevertheless 
their activity or protein levels could change in the absence of changes in mRNA levels. Altogether, we 
have identified hundreds of genes (n = 223) exhibiting coordinate increases in both transcription and 
RNA decay, including key steroidogenic genes, and putative RBPs regulating AngII-induced post-
transcriptional regulatory dynamics. 
 
Ex vivo steroidogenic response in primary human adrenocortical cells 
Although the expression dynamics in H295R cells stimulated with AngII suggested a key role for RBP-
mediated RNA decay, the extent to whether these expression changes occur in normal human 
adrenocortical steroidogenesis is unclear. Therefore, we performed RNA-seq in adrenocortical cells 
isolated from the adrenal gland of a tissue donor and treated ex vivo with either AngII or ACTH or basal 
media for 3 or 24 hrs in triplicate (Figure 4A, Supplemental Tables 6 and 7) (Xing et al. 2010, 2011). 
We included ACTH, which stimulates the production of cortisol by the zona fasciculata, because H295R 
cells do not correspond to a specific adrenocortical zone but produce cortisol and androgens in addition 
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to aldosterone when stimulated with AngII (Parmar et al. 2008). Replicates were highly correlated and 
clustered by treatment condition and time (Supplemental Figure 4A). PCA analysis revealed that 
compared to basal media cells treated with ACTH exhibited more differences than those treated with 
AngII (Figure 4B). Across all conditions, we detected 3217 genes with significantly different expression 
levels (FDR <0.05). Consistently, we detected substantially more statistically significant expression 
changes induced by ACTH versus AngII at 3hrs and 24 hrs (Supplemental Figure 4B, left and right, 
respectively). However, the expression changes for genes with significant differential expression upon 
either ACTH or AngII treatment (n=3217) were strongly positively correlated. This indicated that the 
differences between ACTH and AngII were more quantitative (magnitude of the expression change) 
rather than qualitative (completely different genes changing) (Figure 4C). Consistent with hormone 
production, both AngII and ACTH resulted in the induction of genes encoding key steroidogenic 
enzymes (Figure 4D). Finally we tested if the AngII-induced changes were recapitulated in the ex vivo 
stimulation paradigm using gene set enrichment analysis (GSEA) (Tamayo et al. 2005). Indeed, as2 
genes, which were robustly and rapidly induced by AngII in H295R cells, were significantly upregulated 
after ex vivo treatment of primary adrenocortical cells with ACTH (Figure 4E, top left) and AngII (Figure 
4E, bottom left) for 3 hours. Likewise, as4 genes, which also exhibited a robust albeit delayed induction 
in response to AngII in H295R cells, were significantly upregulated after ex vivo treatment of primary 
adrenocortical cells with ACTH (Figure 4E, top right) and AngII (Figure 4E, bottom right) for 24 hours. 
We found 154 RBPs among the union of differentially genes, including ones that were differentially 
expressed upon AngII treatment of H295R cells, such as CPEB4, MBNL1, MBNL2, MSI2, PEG10, 
ZFP36, and ZFP36L2. Overall, we found strong concordance between the direction and timing of 
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RNA-binding proteins regulate aldosterone levels 
Given the agreement in direction and timing of the steroidogenic gene expression response between 
H295R and primary human cells, we performed an siRNA screen to identify RBPs that regulate 
aldosterone levels in H295R cells. We selected 16 candidates from an annotated list of 1542 human 
RBPs (see (Gerstberger et al. 2014)) based on 1) differential expression upon AngII treatment in H295R 
cells; 2) high expression in H295R cells; 3) high and adrenal gland-specific RNA expression across 
normal human tissues, and 4) RBP motifs enriched in the 3’ UTRs of unstable and destabilized mRNAs 
(Figure 5A). Due to our inclusion criteria the candidate RBPs were not all known decay factors (e.g. 
TRUB1 or PELO). We used independent siRNAs for each candidate RBP and measured aldosterone 
levels in cell supernatants 24 hrs after treatment with either vehicle or AngII (see methods for details). 
Aldosterone levels were normalized by cell viability and compared to a mock electroporation control for 
both unstimulated and stimulated cell supernatants (Supplemental Figure 5A, Supplemental Table 8). 
As expected, the depletion of the key steroidogenic transcription factor SF-1 (NR5A1) resulted in loss 
of aldosterone. Five RBPs exhibited statistically significant increases in aldosterone levels by two 
independent siRNAs in AngII stimulated cell supernatants (Figure 5B). Among these putative 
repressors of aldosterone were regulators of global RNA decay (BTG2), ARE-decay (ZFP36L1 and 
ZFP36L2), and a psuedouridine synthase (TRUB1). We identified 3 potential RBPs for which two 
independent siRNA knockdowns resulted in decreased aldosterone levels suggesting they promote 
aldosterone production (Figure 5C). Specifically, these putative activators of aldosterone were a 
splicing factor (MBNL2), an RNA decay factor (CPEB4), and a signaling scaffold and RNA localization 
factor (AKAP1). For the seven other RBPs we either observed no change and/or conflicting results for 
the different siRNAs (HNRNPL, MBNL1, PEG10, PNRC2, ZFP36), or we only screened a single siRNA 
(MSI2 and PELO) (Figure 5D). Knockdown of RBPs resulted in similar, but more subtle effects on 
aldosterone levels in unstimulated cells, which was to be expected given the minimal amounts of 
aldosterone produced in the absence of AngII (Supplemental Figure 5 B-D). Interestingly we observed 
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potential functional redundancy between the ZFP36 family members. Depletion ZFP36L2,  which is the 
most abundant family  member by mRNA expression, had the most consistent and potent increase in 
aldosterone levels (Supplemental Figure 5E). These data revealed eight RBPs (10 including RBPs 
targeted by a single siRNA) that either activated or repressed aldosterone production. Seven of the ten 
RBPs were induced by AngII stimulation, which could indicate an increase in their respective post-
transcriptional regulatory activity (Supplemental Figure 5F). 
 
BTG2 temporally restricts AngII-induced activation kinetics 
We decided to investigate how BTG2 controls the AngII gene expression response. BTG2 promotes 
general RNA decay through deadenylation (Mauxion et al. 2008) and represses aldosterone production 
(Figure 5B). Both BTG2 mRNA (Figure 6A) and protein (Figure 6B) were rapidly induced by AngII 
stimulation each peaking at ~3 hours. Therefore, we hypothesize that BTG2 actively promotes the 
resolution of aldosterone production. We performed RNA-seq of siRNA knockdown of BTG2 in H295R 
cells that were unstimulated or AngII-stimulated for 6hrs and 24 hr and performed RNA-seq in duplicate 
(Supplemental Table 9). As expected, BTG2 mRNA levels were lower across all time points in the 
BTG2 depletion compared to the mock depletion (Supplemental Figure 6A). Next, we assessed the 
overlap between mRNAs upregulated or downregulated by BTG2 depletion with the AngII-response 
clusters. We found that mRNAs upregulated upon BTG2 depletion were strongly enriched in the as3, 
as4 classes and modestly enriched in aw1-aw4 classes (Figure 6C). This is consistent with the 
propensity for these clusters to contain mRNAs exhibiting increases in RNA decay during 
steroidogenesis (Figure 3C). Transcripts encoding critical pro-steroidogenic factors and enzymes that 
were induced by AngII exhibited increased upregulation in the BTG2 depleted cells (Figure 6D), while 
unchanged mRNAs were not altered by BTG2 (Figure 6D, right). Altogether, these data are consistent 
with a model in which BTG2 is induced by AngII to upregulate the decay of mRNAs encoding pro-
steroidogenic factors to prevent overproduction of aldosterone. 
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DISCUSSION 
Despite our current understanding of adrenocortical steroidogenesis, the fundamental regulatory 
networks that govern aldosterone homeostasis remain unclear. Our data indicate that AngII stimulation 
increases both mRNA production and decay to rapidly implement and resolve a pro-steroidogenic gene 
expression program. The AngII-induced expression dynamics in H295R cells are likely to be 
physiologically relevant since they were largely recapitulated in primary human adrenocortical cell 
stimulated with AngII and ACTH. This regulatory scheme enables the robust production of aldosterone 
while also preventing overproduction. The depletion of multiple factors promoting RNA decay, which 
themselves were upregulated by AngII, resulted in an excess of aldosterone. The additional energy 
expenditure of increasing both transcription and decay may represent the cellular cost for the absence 
of a mechanism to store aldosterone within the cell and release it in response to stimulus. It will be 
interesting to determine if this coupling is disrupted by mutations driving primary aldosteronism. 
 
RNA decay temporally coordinates aldosterone production 
The stimulation response of adrenocortical cells to AngII resembles an impulse (or single pulse) pattern 
consistent with functional higher order temporal coordination. This system exhibits both regulatory 
modules (12 clusters in Figure 1D), which consists of co-expressed genes with the same temporal 
pattern, which reflects a particular sequential order or cascade of gene or module expression (Yosef 
and Regev 2011). The mRNAs in the regulatory modules encoded functionally related proteins that 
play distinct roles at specific times during the AngII response. For example, expression levels of mRNAs 
encoding transcription factors and RBPs peaked within the first few hours, while those encoding 
steroidogenic enzymes peaked 6-8 hours post stimulation. Indeed, the temporal coordination of 
expression of these distinct factors is consistent with previous characterization of early and late steps 
of steroidogenesis (Nogueira et al. 2009). Our data suggest that both transcriptional cascades and 
intrinsic differences in RNA decay rates determine the kinetics of the AngII gene expression response. 
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Specifically, the decay rate of transcriptionally induced mRNAs is inversely proportional to the time to 
peak expression. Therefore, RNA decay is critical for temporally coordinating the response time of 
these regulatory modules and consequently aldosterone homeostasis. Our findings are similar to the 
observed role RNA decay in coordinating immune and inflammation responses (Hao and Baltimore 
2009; Elkon et al. 2010; Rabani et al. 2011). The temporal coordination of these regulatory modules by 
post-transcriptional regulation may be examples of dynamic RNA regulons (Keene 2007). Interestingly, 
these observations occur in systems that require a robust, rapid, yet measured production of a 
physiologically potent molecule in either cytokines or steroid hormones. 
 
Coupling of transcription and decay dynamics controls aldosterone homeostasis 
Multiple lines of evidence indicate that one or more mixed incoherent feedforward loops (MIFFL) ensure 
the proper promotion and resolution of steroidogenesis (Figure 6E). Specifically, AngII promotes the 
transcriptional upregulation of both pro-steroidogenic factors (STAR, CYP11B2) and RNA metabolism 
factors (BTG2, ZFP36L2) that negatively regulate the expression of pro-steroidogenic factors. These 
Incoherent feedforward loops have largely been examined with respect to transcription factors and 
miRNAs and are a recurrent motif to enhance the robustness (Tsang et al. 2007; Shalgi et al. 2007). 
Transcription factor and RBP versions of these motifs remain poorly characterized (Joshi et al. 2012), 
with the exception of the RBP ZFP36 (TTP) in macrophage activation models (Rabani et al. 2014). 
Nevertheless, the behavioral benefits associated with incoherent feedforward loops include the 
production of pulse-like patterns, faster response times to stimulation, output  noise buffering, and even 
detection of fold-change in expression (Basu et al. 2004; Mangan et al. 2006; Goentoro et al. 2009; 
Siciliano et al. 2013). These features would be invaluable for facilitating the rapid production and 
resolution of the response to AngII stimulation to maintain proper aldosterone homeostasis. However 
due to a combination of technical limitations and need for additional experimentation, we do not know 
which of those features that BTG2 contributes to. H295R cells are difficult to transfect and it is 
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imperative to develop stable models for controlling gene dose, which we are developing using 
CRISPR/Cas9. Additionally, we would gain sensitivity by employing recently developed methods that 
provide a direct readout of newly synthesized vs pre-existing RNAs in the same sample (Herzog et al. 
2017; Schofield et al. 2018). Thus, we are likely underestimating the true number of RNAs exhibiting 
changes in decay rates during steroidogenesis. Furthermore, we do not know the identity of the 
transcription factor(s) promoting synthesis of mRNAs encoding pro-steroidogenic proteins and BTG2, 
though SF1 (NR5A1) and CREB1 are the most likely candidates (Nogueira and Rainey 2010; Selvaraj 
et al. 2018; Clark and Combs 1999; Caron et al. 1997). The RBPs ZFP36L1 and ZFP36L2 are both 
induced by AngII and bind to AREs in the 3’ UTR of target mRNA to promote decay and may be 
additional repressors. Consistent with our expectation, ZFP36L1 was shown to suppress ACTH-
stimulated STAR mRNA induction in bovine adrenocortical cells and mouse cell lines (Duan et al. 2009). 
However, this was mediated via ZFP36L1 binding to AREs in an alternative 3’ UTR that we did not 
detect in our RNA-seq data from H295R or human adrenocortical cells. Finally, BTG2 depletion only 
deregulated a subset of mRNAs, which suggests that BTG2 may synergize with specific RNA-decay 
pathways as previously postulated (Stupfler et al. 2016). 
 
Dynamic RNA regulatory network controlling steroidogenesis 
We have uncovered a novel paradigm by which RBAs and regulated RNA decay control the kinetics of 
AngII-stimulated gene expression to facilitate the implementation and resolution of pro-steroidogenic 
gene expression and metabolic programs required for proper aldosterone production in humans. In 
addition to RNA decay factors, we identified the RNA modification enzyme TRUB1 was also a repressor 
of steroidogenesis. TRUB1 is a psuedouridine synthase that modifies tRNAs and mRNAs (Safra et al. 
2017). We also identified numerous activators of aldosterone production. We found that the signaling 
scaffold protein AKAP1 activates aldosterone production, which is consistent with a proposed role for 
AKAP1 in promoting the localized translation of STAR mRNA at the mitochondria (Dyson et al. 2008; 
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Grozdanov and Stocco 2012). Additional activators identified include the cytoplasmic RBPs CPEB4, 
MSI2, and PELO, which regulated stability and translation, as well as, MBNL2 a well-known splicing 
factor. The majority of these RBPs have not  previously been associated with aldosterone production 
or steroidogenesis. The identification of activators and repressors is not surprising given the 
dysregulation of aldosterone homeostasis has pathological consequences. Dissecting the role of 
combinatorial regulation by RBPs in the dynamic steroidogenic regulatory network will undoubtedly 
reveal novel points of control. Since the adrenal cortex is amenable to the delivery of modified 
oligonucleotides (Biscans et al. 2019), the RBP-RNA regulatory interactions may be targeted for 
disruption to precisely and specifically modulate steroidogenesis. 
 
METHODS  
See supplemental methods for more details. 
 
Cell culture 
H295R cells were cultured in complete media containing DMEM:F12 with 10% Cosmic Calf Serum 
(Hyclone: SH30087.03) and 1% ITS+ Premix (Corning: 354352). H295R cells were stimulated with 10 
nM Angiontensin II (Sigma: A9525) after being in low sera media for 24 hrs (DMEM/F12 with 0.1% 
CCS, 1% ITS).  
 
Primary human adrenal cells were isolated and cultured as described previously (Xing et al. 2010; Rege 
et al. 2015). Primary adrenal cells were plated at a density of 20,000 cells/well (48 well dish) in growth 
medium and grown to 60% confluence after which they were starved in low serum medium 18 hours 
prior to treatment with either 10 nM AngII or 10 uM ACTH. 
 
Gene expression measurements 
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H295R cells were collected in TRIzol and RNA was isolated using ZYMO Research DirectZol Miniprep 
Plus kit following the manufacturer’s instructions with on-column DNase I digestion. RNA was collected 
from ex vivo stimulated primary adrenal cells using the Qiagen RNEasy MiniPrep Plus kit following the 
manufacturer’s instructions and eluted into nuclease-free water. 
 
RT-qPCR 
Reverse transcription was performed using 100 ng of RNA input for the Bio-Rad iScripit kit and qPCR 
using Bio-Rad iTaq Universal SYBR Green Supermix on a Bio-Rad CFX 384 qPCR instrument. 
Analysis of qPCR was performed using the delta-delta Cq method normalizing to GAPDH and 
unstimulated controls. 
 
Metabolic labeling experiments 
We performed 4-thiouridine (4sU) experiments as described previously (Mukherjee et al. 2017). Briefly, 
H295R cells were treated for a 20-minute pulse with 500 uM 4sU. RNA was extracted and split into 
input and biotinylated samples. The biotinylated RNA was immunoprecipitated using streptavidin beads 
and both input and immunoprecipitated RNA was subject rRNA depletion using RiboZero and 
sequenced using the qRNA-seq kit (BIOO scientific). 
 
RNA-seq and regulatory analysis 
Salmon (Patro et al. 2017) was used for quantifying transcript levels from all libraries using Gencode 
v26. A custom salmon index containing Gencode v26 precursor and mature transcripts and ERCC 
spike-ins as was used previously (Mukherjee et al. 2017). All downstream analysis was performed in 
R and detailed in the Supplemental Methods. Unstimulated (initial) RNA decay rates were estimated 
using 4sU metabolic labeling data and the INSPEcT R package (de Pretis et al. 2015). 
Overrepresentation of 7mers was calculated via Cwords (Rasmussen et al. 2013) from 3’UTR 
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sequences ranked by unstimulated RNA decay rates. RBP motifs enrichment was calculated using 
https://github.com/TaliaferroLab/FeatureReachR. Determining RNA stability changes during the time 
course used salmon-quantified intronic and exonic reads, adapting the Exon-Intron Split Analysis 
concept implemented in eisaR (Gaidatzis et al. 2015).  
 
Aldosterone screen 
H295R cells (2.5M) cultured in complete media were electroporated with 10 uM siRNA (Thermo Fisher 
Scientific - see supplement for catalog numbers) and plated in a 96-well plate. After 24 hrs, half the 
wells had media was replaced with low sera media and the other half with low sera media containing 
AngII. After 24hrs, aldosterone levels in the supernatant were measured using Aldosterone Competitive 
ELISA kit (ThermoFisher) and cell viability measured from the cells using PrestoBlue reagent 
(ThermoFisher) by reading fluorescence on a BioTek Synergy HT plate reader. Each plate contained 
a mock transfection that we normalized to for calculating aldosterone levels in each siRNA experiment 
while taking plate batch effects and cell viability into account. 
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Figure 1 – High-resolution AngII-response kinetics in H295R cells. A) Cartoon of AngII treatment 
timecourse RNA-sequencing experiment. Total RNA is depleted for rRNA and precursor and mature 
RNA expression levels are calculated allowing modeling of synthesis and decay. B) Scatter plot of the 
first two principal components calculated on a matrix of the mean expression level for each expressed 
gene at each time point (colors) after AngII stimulation. C) Violin plot of the distribution of genes 
exhibiting statistically significant AngII-induced changes in expression per timepoint and category. D) 
Line plot depicting the average change in expression (error bar represents standard error) relative to 
unstimulated cells for each group of genes with similar response kinetics determined by k-means 
clustering. Each color represents a specific group of genes with the name defined by the direction, 
shape, and timing of the AngII-induced response. E) Heatmap of selected gene sets (Molecular 
Function ontology) that are significantly enriched in the AngII response groups. F) Heatmap of log2-
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based fold changes in pre-mRNA and mature mRNA levels upon AngII stimulation compared to 
unstimulated cells for mRNAs encoding key steroidogenic enzymes.  
 
Figure 2 – The influence of RNA decay on AngII response kinetics. A) Distribution of time to peak 
response for all RNAs per cluster (left). Distribution of decay rates in unstimulated cells for all RNAs 
per cluster determined from 4sU-labeling experiments (right). B) Scatter plot of the average decay 
rate and peakiness for activated RNAs. C) Scatter plot of the p-value and enrichment of RBP motifs 
from in the top 500 7mers found in the 3’ UTR of RNAs with high decay rates in unstimulated cells.  
 
Figure 3 – Dynamic changes in RNA decay during steroidogenesis. A) Line plot of fold change in 
pre-mRNA (black) and mRNA (red) expression for mRNAs encoding enzymes responsible for 
conversion of cholesterol to aldosterone (top-to-bottom). Pearson correlation coefficient between 
changes pre-mRNA and mRNA for each gene (top right). B) Distribution of Pearson correlation 
coefficient between pre-mRNA and mRNA changes for each gene across all time points for each 
response cluster. C) Heatmap of the odds ratio for the overlap between response cluster membership 
and RNAs exhibiting evidence for stabilization, destabilization, or neither as determined by EISA 
(yellow indicates more overlap). D) Line plot of median fold change in pre-mRNA (left) and mRNA 
(right) expression for genes in as4 (top) or aw3 (below) with either evidence for destabilization (blue) 
or no change in post-transcriptional regulation (black). Error bar represents standard error. E) Line 
plot of mean fold change in pre-mRNA (black) and mRNA (red) expression for example genes from 
as3 (top) or aw3 (below) and evidence for destabilization (left) or no difference in decay rates (right). 
F) Scatter plot of the p-value and enrichment of RBP motifs in 5mers within the 3’ UTR of destabilized 
mRNAs in aw3 versus 3’ UTRs of non-differentially expressed mRNAs. 
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Figure 4 – Gene expression dynamics of ex vivo stimulated primary human adrenocortical 
cells. A) Ex vivo stimulation of cortical cells isolated from normal human adrenal glands treated with 
AngII, ACTH, or basal media for 3 or 24 hours. Strand-specific paired-end RNA-seq was performed in 
triplicate on polyadenylated RNA. B) Scatter plot of the first two principal components calculated on a 
matrix of the mean expression level for each expressed gene at each time (label) and treatment 
(color). C) Barplot of the Pearson correlation coefficient between AngII-induced and ACTH-induced 
changes in gene expression versus basal cells for the union of genes exhibiting statistically significant 
changes in expression in any condition/time. Correlation coefficients for comparisons of the same 
stimulation time are colored red. D) Heatmap of log2 fold change in expression difference for 
stimulated (ACTH on left, AngII on right) vs basal for mRNAs encoding key steroidogenic enzymes. 
F) GSEA running enrichment plots depicting the enrichment of as2 (left) and as4 (right) gene sets 
representing clusters of genes with similar AngII-induction kinetics in H295R cells (see Figure 1D) in 
a list of genes ranked by the fold change upon ex vivo stimulation of primary human adrenocortical 
cells with ACTH (top) or AngII (basal) versus basal media. 
 
Figure 5 – Regulation of aldosterone by RBPs in AngII stimulated cells. A) Boxplots of all RBPs 
(grey) and candidate RBPs (red) for change in expression upon AngII stimulation (left), human 
adrenal tissue expression levels (center), and adrenal tissue specificity scores (right). Barplot of the 
change in aldosterone concentrations for knockdowns resulting in B) increased aldosterone 
concentration, C) decreased aldosterone concentration, and D) discordant or single siRNA results. 
Aldosterone levels were measured using ELISA from supernatants of H295R cells electroporated with 
siRNAs targeting candidate RBPs and stimulated with AngII for 24 hrs. The y-axis represents the 
change in aldosterone concentration versus mock electroporation (see methods). The error bars 
represent the standard error of at least 6 replicates. RBPs are color-coded by their known function. 
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Figure 6 - BTG2 constrains AngII RNA expression kinetics to prevent aldosterone 
overproduction. A) Line plot of fold change in BTG2 mRNA levels in response to AngII. B) Western 
blot of BTG2 and B-Tubulin protein levels in response to AngII. C) Heatmap of the odds ratio for the 
overlap between response cluster membership and RNAs exhibiting downregulation, no change, or 
upregulation upon BTG2 siRNA depletion 24 hours after AngII stimulation (yellow indicates more 
overlap). D) Barplot of expression levels of mRNAs encoding key AngII-induced steroidogenic 
proteins exhibiting statistically significant upregulation (p<0.05, DESeq2) upon BTG2 siRNA depletion 
during AngII stimulation. Error bars represent standard deviation. E) Model for incoherent feedforward 
loop employing increases in transcription and RNA decay to coordinate AngII stimulation kinetics to 
ensure the appropriate production of aldosterone. 
 


























































































AngII treatment time (hrs)
AngII treatment time (hrs)



























































































































































































response to calcium ion
corticosterone response
mineralocorticoid response
negative reg. of ERK1/ERK2
PDGFR signaling pathway
PERK-mediated UPR
response to corticosteroid stimulus
p38 MAPK cascade
spliceosomal complex assembly
mRNA splice site selection




transcription response to ER stress
reg. of adherens junction organization
ER nucleus signaling pathway
activation ofMAPKKK activity
3' UTR mediated mRNA destabilization
mRNA cis splicing via spliceosome
formation of SL/U4/U5/U6 snRNP
hormone biosynthetic process
mineralocorticoid biosynthetic process
negative reg. of cold induced thermogenesis
smooth muscle cell differentiation







































































































































































0 5 10 15 20 25
time (hrs)time (hrs)
GPRC5A








































































































































activated weak 3 (aw3)
pre-mRNA mRNA














activated strong 4 (as4)
pre-mRNA mRNA


















































































Log₂ Fold Change in
































































































































































































































































































































 Cold Spring Harbor Laboratory Press on June 3, 2021 - Published by rnajournal.cshlp.orgDownloaded from 
mock BTG2 siRNA
0 6 240 6 24




























































































































































































































- faster response time














































































∆ mRNA upon BTG2 depletion
Figure 6
 Cold Spring Harbor Laboratory Press on June 3, 2021 - Published by rnajournal.cshlp.orgDownloaded from 
 published online June 1, 2021RNA
  
Rui Fu, Kimberly Wellman, Amber Baldwin, et al. 
  
steroidogenic cells














manuscript is likely to differ from the final, published version. 










(Attribution 4.0 International), as described at 




 click here.top right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the
 http://rnajournal.cshlp.org/subscriptions
 go to: RNATo subscribe to 
Published by Cold Spring Harbor Laboratory Press for the RNA Society
 Cold Spring Harbor Laboratory Press on June 3, 2021 - Published by rnajournal.cshlp.orgDownloaded from 
